chrisvoncsefalvay/vaers-outcomes huggingface dataset:
feeling rundown; feeling sick; headache; Flu like symptoms; Chills; intermittent fever/ low grade fever; This is a spontaneous report from a contactable consumer (patient). A 36-year-old male patient received first dose of BNT162B2 (lot number: EK5730, expiration date: Mar2021), via an unspecified route of administration, in left arm on 20Dec2020 at single dose for COVID-19 immunization. His work was offering the vaccine to them, and he was a first responder, so he went to the hospital where they were administering it. Medical history was none. There were no concomitant medications. The patient received no other vaccines or new medications with the COVID-19 vaccine. The patient experienced headache, flu like symptoms and chills on 20Dec2020 and intermittent fever in Dec2020. The patient was a first responder who received the COVID-19 vaccine on 20Dec2020. He experienced headache, flu like symptoms and intermittent fever. The patient stated that he started feeling "a little bit better" for a couple of days but now he has a fever again. His work had him take a COVID-19 test on 24Dec2020 due to his symptoms and he was negative. He was asking what he should do since he is experiencing continued symptoms. The patient said he has some questions about the COVID vaccine, since he received the first dose on 20Dec2020. He said that the day he had it he had a bad headache, chills, and flu like symptoms, then the next day the same thing, then later that night a fever, then the next day a fever. He said on Christmas Eve he got a COVID test to rule it out, and the test was negative. He said he was feeling better, then on 27Dec2020 he started feeling sick with a fever, then on 28Dec2020 a low grade fever and feeling rundown. The patient said he had a nasal swab COVID-19 test done, the one with 3-5 days for results. He said that the test itself was done on 24Dec2020. He said that the temperature for his low grade fever was 100.3 degrees Fahrenheit. His question was about the side effects, since he knew that these are listed that they can be side effects. He said it just kind of worries him since he felt better and now he feels sick again and popped a fever. He said that he called his doctor, and they said they are not gonna do a second COVID test, and told him to rest. He said he doesn't think this is normal though. Treatment of the events included Ibuprofen. The patient clarified to Advil. He said he took the recommended dose of two pills, 200 mg each. Advil: UPC: Unknown, Lot: DL9107 EXP: Jan2023. He said he took the Advil maybe once a day, the first two days. The lab test included temperature: 100.3 degrees Fahrenheit in Dec2020 and COVID-19 nasal swab test: negative on 24Dec2020. The outcome of the events was unknown.
pt recvd vax MAR93 & 24 hrs following vax exp a sz; pt felt that exp was not related to vax; No further details were provided
pt had recent exposure to varicella & recv varicella vax on 31MAY96 instead of varicella zoster immune globulin;pt pregnant;pt devel HTN during pregnant;also intrauterine growth retardation;devel eclampsia, grand mal sz, cerebral infarction
UNBALANCED FEELING; BLURRY VISION; MORE INTENSE AND MORE FREQUENT HEADACHES; UNSTEADY FEELING / DISEQUILIBRIUM; This spontaneous report received from a patient concerned a 45 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: dander allergy, and developed shrimp allergy a couple of years ago, and other pre-existing medical conditions included: Patient did not had acute symptoms after vaccination for few months. He was active and in good physical shape. Patient wears contact lens. The patient experienced drug allergy when treated with ciprofloxacin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A, and expiry: 21-SEP-2021) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On SEP-2021, the patient experienced unsteady feeling / disequilibrium. On an unspecified date, the patient experienced unbalanced feeling, more intense and more frequent headaches, and blurry vision. Laboratory data (dates unspecified) included: Eye exam (NR: not provided) 20/20. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the unbalanced feeling, more intense and more frequent headaches, unsteady feeling / disequilibrium and blurry vision was not reported. This report was non-serious.
pt recvd vax; woke up in severe pain rt side radiating to back; spasms/pain cont for 2 hrs; subsided when took apap; saw MD 1nov94MD did not feel due to flu vax but did lots of tests;cont nauseated & apin behind Lt arm as of 4nov94;
sore arm; headache; full week of head cold (sneezing, runny nose, congestion); full week of head cold (sneezing, runny nose, congestion); full week of head cold (sneezing, runny nose, congestion); full week of head cold (sneezing, runny nose, congestion); fatigue; This is a spontaneous report from a non-contactable 32-year-old -female consumer(patient) reported for herself.  A 32-year-old female patient (not pregnant at the time of vaccination) received first dose of bnt162b2 (PFIZER-BIONTECH COVID -19 VACCINE, solution for injection, Lot Number: EP7533, Expiry date: unknown) via an unspecified route of administration, administered in left arm on 01Apr2021 at 16:00 as dose 1, single for COVID-19 immunization. Medical history included known allergies Sulfa. Concomitant medication(s) included etonogestrel (NEXPLANON), spironolactone (SPIRONOLACTONE), bupropion (BUPROPION) and citalopram (CITALOPRAM). Patient did not have covid prior vaccination and has not been tested covid post vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On an unspecified date, the patient experienced sore arm, headache, full week of head cold, full week of head cold (sneezing, runny nose, congestion), and fatigue. It was reported that after First Shot: sore arm, headache, fatigue, full week of head cold (sneezing, runny nose congestion). The patient did not receive any treatment for the events. The outcome of events were unknown.  No follow-up attempts are needed. No further information is expected.
Patient reports severe pain in arm, unable to lift arm, and pain between her shoulder blades.  Patient took a pain pill but stated that that did not even touch the pain.  She was encouraged to seek medical advice from a healthcare practitioner.
little brain foggy (1st dose); This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (little brain foggy (1st dose)) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included Kidney transplant. Concurrent medical conditions included Immunocompromised. Concomitant products included Prednisone 5 mg, BELATACEPT and MYCOPHENOLATE MOFETIL HYDROCHLORIDE (CELLCEPT [MYCOPHENOLATE MOFETIL HYDROCHLORIDE]) for Kidney transplant.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (little brain foggy (1st dose)). At the time of the report, FEELING ABNORMAL (little brain foggy (1st dose)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: negative (Negative) negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient is immunocompromised, because she had a kidney transplant and is taking immunosuppressive medications.  Treatment Tylenol after third dose   This case was linked to MOD-2021-345487 (Patient Link).
He was feeling worse since the last report; using a walker again; He has lost 22 lbs; Hard time getting out of bed; Dizzy/dizziness; Ability to walk has been reduced; fatigue (he barely gets out of bed); Chills; Fever 102F; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy/dizziness), WALKING DISABILITY (Ability to walk has been reduced), FEELING ABNORMAL (He was feeling worse since the last report), WALKING AID USER (using a walker again) and WEIGHT DECREASED (He has lost 22 lbs) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 29-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, the patient experienced PYREXIA (Fever 102F) and CHILLS (Chills). On 02-May-2021, the patient experienced DIZZINESS (Dizzy/dizziness), WALKING DISABILITY (Ability to walk has been reduced), WEIGHT DECREASED (He has lost 22 lbs) and FATIGUE (Hard time getting out of bed). 02-May-2021, the patient experienced FATIGUE (fatigue (he barely gets out of bed)). On 07-May-2021, the patient experienced FEELING ABNORMAL (He was feeling worse since the last report) and WALKING AID USER (using a walker again). The patient was treated with PARACETAMOL (TYLENOL) on 30-Apr-2021 for Fever and Chills, at a dose of 1 dosage form and MECLOZINE HYDROCHLORIDE (ANTIVERT [MECLOZINE HYDROCHLORIDE]) on 02-May-2021 for Dizziness, at a dose of 1 dosage form. On 02-May-2021, PYREXIA (Fever 102F) had resolved. On 05-May-2021, WALKING DISABILITY (Ability to walk has been reduced) and FATIGUE (Hard time getting out of bed) had resolved. At the time of the report, DIZZINESS (Dizzy/dizziness), FEELING ABNORMAL (He was feeling worse since the last report), WALKING AID USER (using a walker again), WEIGHT DECREASED (He has lost 22 lbs), FATIGUE (fatigue (he barely gets out of bed)) and CHILLS (Chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications provided Treatment included  fluids   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Added four additional events Feeling abnormal, Walking aid user, Fatigue and Weight decreased On 07-May-2021: Follow-up document does not contain any new information On 10-Jun-2021: Follow-up document does not contain any new information
30 patients had been administered a dose past the 30 day mark (expired); Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (30 patients had been administered a dose past the 30 day mark (expired)) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (30 patients had been administered a dose past the 30 day mark (expired)). At the time of the report, EXPIRED PRODUCT ADMINISTERED (30 patients had been administered a dose past the 30 day mark (expired)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
No adverse reactions noted: was given a 0.25ml flu vaccination with preservatives instead of preservative free.
THE VACCINE REFRIGERATOR WENT OUT WHICH CAUSED THE IPOL AND MMR VACCINES TO BE COMPROMISED. NO ADVERSE EFFECTS HAVE BEEN REPORTED. THE PATIENT WILL BE REVACCINATED AT A LATER DATE.
8/27/2021. Cardiac arrest. Ventricular tachycardia. Possible Post COVID-19 vaccine myocarditis vs. cardiac vasospasm. Amiodarone, therapeuric cooling, Levophed. Aspiration pneumonia secondary to cardiac arrest
Polyarticular arthritis within 3days of vaccine administration. Infant was admitted with lab samples taken from CSF, blood and urine. He was given pain medication.  4/21/09 Received hospital medical records of 3/22-3/24/2009. FINAL DX: joint swelling, possible vaccine reaction; fever Records reveal patient experienced fever x 2 da & redness/warmth/swelling of elbows, feet & knees x 1 da w/irritability when picked up or moved.  Tx w/IV antibiotics & tylenol.  Rheum consult done.  Improved & d/c to home on no meds w/PCP f/u.
Hives or red rash torso, front and back, down arms and groin - not itchy; Fever; Body aches; Chills; Fatigue; Headache; This is a spontaneous report from a contactable other healthcare professional, the patient. A 61-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 30Mar2021 at 13:00(at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included moderate and controlled asthma and environmental allergy. Concomitant medications included allergy shots taken monthly. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number:EN6205) via an unspecified route of administration in the left arm on 10Mar2021 (at the age of 61-years-old) as a single dose for COVID-19 immunisation.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 16:00 the patient experienced  within 3 hours of Pfizer booster(second dose), chills, headache, fatigue. The patient woke up on 31Mar2021 with fever(100.2), exhaustion, body aches, chills, headache. The patient woke up on 01Apr2021 with red rash/hives all over her torso, front and back, down her arms, and in groin which was not itchy. All other symptoms continued. The next day, 02Apr2021 was same as the last day. On 03Apr2021 the patient experienced the first day without  headache, chills, fever, exhaustion and hives were fading. Therapeutic measures were taken as a result of the reported adverse events and included treatment with Tylenol, 650 mg every 4 hours started on 30March2021 to 02Apr2021(4 days). Lab test included body temperature on 30Mar2021 and the result was 100.2. The clinical outcome of the events headache, chills, fever and exhaustion was recovered on 03Apr2021. The clinical outcome of the events hives and body aches were recovering at the time of this report.    No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. On 25-JUN-2015, the patient was vaccinated with improperly stored dose of ROTATEQ oral, lot # K011947, expiration date 07-JUN-2016. No adverse events were reported. This is one of several reports received form the same source. Additional information has been requested.
Unevaluable react: organ transplant recepient rcv'd inject of Flu Shield (1999-2000 Formula) & almost died. No further info is available as of date of this report.
Recieved vaccine; waited 15 minutes; left facility and was 1/2 mile away per car when child noted appearance of hives.  Returned to vaccine clinic.  Given Epinephrine IM in Rt. Deltoid at 12:35pm.  911 called.  Child shakey.  States "I feel like I took 5 energy drinks all at once.  Color pale.  Covered with blanket.  B/P 122/68 and radial pulse=104.   Hives noted to be fading.  At 12:45 emergency personel had arrived and child transferred to local ER.  Client given prescriptions for steroid, prilosec and an allergy pill.   Released to home around 3:00pm on 10/20.  However, the child broke out in hives again the next day and continued to suffer sporadic hive breakouts for a few days.
12 hours, post vax, pt had redness and swelling 7-8cm at injection site. Was treated with Benadryl but after 48 hours, was no better.
Pfizer Vaccine Dose 1 2/5/2021 Pfizer Vaccine Dose 2 3/6/2021 COVID positive 3/27/21  3/27/21: Patient was admitted and started on Solu-Medrol, Rocephin, and azithromycin.  Initially had oxygen requirements upward of 6 L. His COVID-19 antigen as well as PCR returned positive.  He had received his 2nd vaccine does 3 weeks prior.  His D-dimer and CRP were low throughout his hospital stay.  Not felt that he needed treatment for his COVID positive.  Had significant purulent sputum production.  Was on CPT with vest therapy as well as Mucinex.  Patient did have significant issues with sundowning and required Seroquel at night as well as sitter at bedside at times.  During the day he was much better. Sputum culture returned with Pseudomonas.  He does have history of bronchiectasis as well as Pseudomonas in his sputum.  Antibiotics were switched to Levaquin for 10 days. Patient's oxygen requirements improved and on the day of discharge needed 2 L which was his baseline.  Patient felt near baseline and wished for discharge home.  He does have a 16 hour care although was recommended that he have 24 hour care given his dementia issues at night.  Also recommended that he not drive.  He complete a prednisone taper as well as 10 days of oral Levaquin.  Did discuss with Pulmonary about his COVID positivity and a COVID antibody was ordered prior to discharge and will need follow-up as an outpatient.  He will follow-up with his pulmonologist and PCP in 1-2 weeks.  4/2/2021: Patient was admitted and started on Solu-Medrol, Rocephin, and azithromycin.  Initially had oxygen requirements upward of 6 L. His COVID-19 antigen as well as PCR returned positive.  He had received his 2nd vaccine does 3 weeks prior.  His D-dimer and CRP were low throughout his hospital stay.  Not felt that he needed treatment for his COVID positive.  Had significant purulent sputum production.  Was on CPT with vest therapy as well as Mucinex.  Patient did have significant issues with sundowning and required Seroquel at night as well as sitter at bedside at times.  During the day he was much better. Sputum culture returned with Pseudomonas.  He does have history of bronchiectasis as well as Pseudomonas in his sputum.  Antibiotics were switched to Levaquin for 10 days. Patient's oxygen requirements improved and on the day of discharge needed 2 L which was his baseline.  Patient felt near baseline and wished for discharge home.  He does have a 16 hour care although was recommended that he have 24 hour care given his dementia issues at night.  Also recommended that he not drive.  He complete a prednisone taper as well as 10 days of oral Levaquin.  Did discuss with Pulmonary about his COVID positivity and a COVID antibody was ordered prior to discharge and will need follow-up as an outpatient.  He will follow-up with his pulmonologist and PCP in 1-2 weeks.
Woke up in am of 3-20-07 with 8 cm redness and swelling on the left deltoid region.  Also complains of some itching.
Severe left shoulder pain with immediate onset. Progressed to impaired range of motion and strength by day 3. Two weeks later and I still have pain, impaired range of motion, weakness, difficulty sleeping. I have been out of work the past 3 days, taken out of work by my Doctor, due to left arm impairments. I need assistance for all activities of daily living at this point due to pain and ROM/strength impairments in my left arm. Doctor diagnosed it as Bursitis, Tendinitis, Subacrominal Impingement, secondary to vaccine.
No symptomatic side effects reported; a patient was inadvertently administered and expired PNEUMOVAX 23; This spontaneous report was received from other and refers to a patient of an unknown age and gender.  The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies, and concomitant therapies were not reported.  On 14-FEB-2023, the patient was inadvertently administered with an expired pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, lot # U018309, expiration date: 08-JAN-2023, administered for prophylaxis (strength, dose and route of administration were not provided). No symptomatic side effects or prior temperature excursion were reported (no adverse event).
Headache, Fever, CoughWheeze, NauseaVomiting, bodyaches Narrative:  reported mild symptoms. Will treat at home with OTC meds  Other Relevant History:
Pt is experiencing pain at site of SHINGRIX. Pt states pain is from neck down to finger tips. She states she is having some difficulty lifting her arm. No systemic sx- no rash or redness at site of injection.No oral or airway issues- breathing comfortably.
is 38 yo healthy G5P 2012 at time of event. -LMP 10/14/2020, EDC 7/21/2021 -Prenatal Ultrasound on 1/15/2021, size consistent with GA, 13 2/7 days, 3 vessel cord, rest WNL -received first Pfizer Covid-19 vaccine 2/10/2021 at  16 0/7 GA -received second Pfizer Covid-19 vaccine 3/1/2021 (19 days from first, NOT recommended 21 DAYS) -3/12/2021 had MFM level II ultrasound for advanced maternal age. -3/12/21 US revealed  early IUGR est. fetal weight 296gm, GA consistent with 19/37 GA, now SINGLE uterine artery and echogenic bowel -Amnio, NITP, TORCH all normal/neg -4/3//21 mother noted no movements, fetal demise confirmed, delivered stillborn 4/4/21
Fragmented sleep, urine breaks, racing heart-aging, tachycardia, labored breathing, fatigue, weak, headache, very cold, arm pain where injected and hot for 2 days, and perspires so badly had to change clothes and sheets. 5/14 still felt tired and slept all morning and missed work. 5/15 I feel normal.
Administer expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) in a 60-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine). On 22-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication and treatment information was reported.
Headache, Injection Site Soreness day 2, SoreThroat, Headache, Cough day 8. COVID Test Neg. Narrative:
permanent injuries; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), in Apr2021 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INJURY (non-serious) with onset Apr2021, outcome "unknown", described as "permanent injuries".  Additional information: The patient reported that I have permanent injuries caused by the Covid-19 pfizer vaccine and I can provide any and all medical information needed to move forward.   The information on the batch/lot number for [BNT162B2] has been requested and will be submitted if and when received.
Chickenpox (Varicella).  Exposure to chickenpox 3 days prior to vaccination.
Patient given HPV - GARDASIL - injection #2, (L) deltoid. Five minutes after injection. patient complained of feeling dizzy. She sat in chair and had a petite mal seizure. Lasted for about 10 sec, then awoke and complained of feeling very sleepy. She became urinary incontinent. Was transported by w/c to bed. V/S taken and was seen by doctor. After one hour pt was d/c with mother and sister. Feeling well and appt made for f/u with doctor and Neurology at  clinic.